<
>
Enasidenib mesylate (1650550-25-6)
Product Summary
Enasidenib mesylate (1650550-25-6) is a first-in-class oral inhibitor for IDH2-mutated AML. Available in CP/EP grades, 98% assay, 2-year shelf life, and custom specifications.
Product Custom Attributes
CAS:
1650550-25-6
Specification:
CP, EP, As Required
M.F.:
C20H21F6N7O4S
M.W.:
569.48
Assay:
98%
Shelf Life:
2 Years
Package:
25kg/drum
Highlight:
FARMASINO Enasidenib Mesylate
,FARMASINO Enasidenib manufacturer
,FARMASINO Enasidenib API
Trading Properties
Stock:
In Stock
Shipping Method:
AIR, Express
Description:
CAS: 1650550-25-6; Enasidenib manufacturer; Enasidenib API; Anti-tumor
Payment Terms:
L/C,T/T
Product Description
Enasidenib Mesylate (1650550-25-6)
Enasidenib is a first-in-class oral selective inhibitor of mutant IDH2 enzymes (isocitrate dehydrogenase 2), indicated for the treatment of adults with relapsed or refractory IDH2-mutated acute myeloid leukemia.
| Product Name: | Enasidenib mesylate |
| CAS No.: | 1650550-25-6 |
| Assay: | 98% |
| Specification: | CP, EP, In-house, as required |
| Molecular Formula: | C20H21F6N7O4S |
| Molecular Weight: | 569.48 |
| Shelf Life: | 2 Years |
| Package: | 25kg/drum |
Related Products
Contact Our Experts And Get A Free Consultation!
Our mission is to offer "High Quality" & "Good Service" & "Fast Delivery" to help our clients to gain more profits.
